Literature DB >> 18640666

Sooty mangabeys and rhesus macaques exhibit significant divergent natural killer cell responses during both acute and chronic phases of SIV infection.

L E Pereira1, R P Johnson, A A Ansari.   

Abstract

A correlation between NK cells and rate of disease progression in HIV-1-infected individuals has been documented. The role NK cells play in disease outcome can optimally be studied in SIV-infected disease susceptible rhesus macaques (RM) and SIV-infected disease resistant sooty mangabeys (SM). In this study, three main subsets of CD16(+)CD56(-), CD16(-/dim)CD56(+) and CD16(-)CD56(-) NK cells have been identified with the predominant CD16(+)CD56(-) subset being primarily responsible for cytolytic activity in both species. Cross-sectional studies revealed a significant decline in the frequency and function of this cytolytic subset in SIV-infected RM while an increase occurred in SIV-infected SM. Longitudinal studies revealed that an earlier NK response during acute infection occurred in all SIV-infected SM and in select SIV-infected RM that eventually controlled viral load set point during chronic infection, suggesting that early NK activity and continued maintenance of this cell lineage may indirectly contribute to disease resistance.

Entities:  

Mesh:

Year:  2008        PMID: 18640666     DOI: 10.1016/j.cellimm.2008.06.006

Source DB:  PubMed          Journal:  Cell Immunol        ISSN: 0008-8749            Impact factor:   4.868


  37 in total

1.  IL-17-producing innate lymphoid cells are restricted to mucosal tissues and are depleted in SIV-infected macaques.

Authors:  H Xu; X Wang; D X Liu; T Moroney-Rasmussen; A A Lackner; R S Veazey
Journal:  Mucosal Immunol       Date:  2012-06-06       Impact factor: 7.313

2.  A CD8α(-) subpopulation of macaque circulatory natural killer cells can mediate both antibody-dependent and antibody-independent cytotoxic activities.

Authors:  Diego A Vargas-Inchaustegui; Thorsten Demberg; Marjorie Robert-Guroff
Journal:  Immunology       Date:  2011-11       Impact factor: 7.397

3.  Innate immune natural killer cells and their role in HIV and SIV infection.

Authors:  Pavel Bostik; Yoshiaki Takahashi; Ann E Mayne; Aftab A Ansari
Journal:  HIV Ther       Date:  2010-07-01

4.  CD16- natural killer cells: enrichment in mucosal and secondary lymphoid tissues and altered function during chronic SIV infection.

Authors:  R Keith Reeves; Jacqueline Gillis; Fay E Wong; Yi Yu; Michelle Connole; R Paul Johnson
Journal:  Blood       Date:  2010-03-25       Impact factor: 22.113

5.  Multiple KIR gene polymorphisms are associated with plasma viral loads in SIV-infected rhesus macaques.

Authors:  Porntip Chaichompoo; Pavel Bostik; Susan Stephenson; Suthiphol Udompunturuk; Jaruda Kobkitjaroen; Kovit Pattanapanyasat; Aftab A Ansari
Journal:  Cell Immunol       Date:  2010-04-01       Impact factor: 4.868

6.  Antiretroviral therapy partly reverses the systemic and mucosal distribution of NK cell subsets that is altered by SIVmac₂₅₁ infection of macaques.

Authors:  Namal P M Liyanage; Shari N Gordon; Melvin N Doster; Poonam Pegu; Monica Vaccari; Nebiyu Shukur; Luca Schifanella; Cynthia A Pise-Masison; Danuta Lipinska; Kamil Grubczak; Marcin Moniuszko; Genoveffa Franchini
Journal:  Virology       Date:  2014-01-21       Impact factor: 3.616

Review 7.  Immune responses during spontaneous control of HIV and AIDS: what is the hope for a cure?

Authors:  A Saez-Cirion; B Jacquelin; F Barré-Sinoussi; M Müller-Trutwin
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2014-05-12       Impact factor: 6.237

8.  Non-linear multidimensional flow cytometry analyses delineate NK cell phenotypes in normal and HIV-infected chimpanzees.

Authors:  Cordelia Manickam; Haiying Li; Spandan V Shah; Kyle Kroll; R Keith Reeves
Journal:  Int Immunol       Date:  2019-03-05       Impact factor: 4.823

9.  Potential confusion of contaminating CD16+ myeloid DCs with anergic CD16+ NK cells in chimpanzees.

Authors:  R Keith Reeves; Tristan I Evans; Patricia N Fultz; R Paul Johnson
Journal:  Eur J Immunol       Date:  2011-03-01       Impact factor: 5.532

10.  Preliminary in vivo efficacy studies of a recombinant rhesus anti-alpha(4)beta(7) monoclonal antibody.

Authors:  L E Pereira; N Onlamoon; X Wang; R Wang; J Li; K A Reimann; F Villinger; K Pattanapanyasat; K Mori; A A Ansari
Journal:  Cell Immunol       Date:  2009-06-26       Impact factor: 4.868

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.